- €837.76m
- €652.64m
- €539.20m
- 95
- 51
- 51
- 76
Annual cashflow statement for Vetoquinol SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 19.2 | 62.9 | 48 | 55.6 | 58.7 |
Depreciation | |||||
Non-Cash Items | 17.6 | 24.6 | 25.3 | 22.6 | 23.6 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 9.23 | -29.4 | -52.9 | -23.3 | -27.1 |
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 92.2 | 89.7 | 62.9 | 89.4 | 85.8 |
Capital Expenditures | -145 | -32.4 | -22.5 | -19 | -17.7 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.321 | -1.04 | 0.979 | 0.129 | 2.03 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -145 | -33.4 | -21.5 | -18.9 | -15.6 |
Financing Cash Flow Items | -5.26 | -0.549 | -0.464 | 1.73 | 4.61 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 102 | -121 | -16.1 | -15.5 | -16 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 45.8 | -61.2 | 25.5 | 52.6 | 56.2 |